Literature DB >> 9249499

Altered vascular function after adenovirus-mediated overexpression of endothelial nitric oxide synthase.

H Ooboshi1, Y Chu, C D Rios, F M Faraci, B L Davidson, D D Heistad.   

Abstract

Gene transfer with replication-deficient adenovirus is a potentially useful tool to study vascular biology. We have constructed a replication-deficient adenovirus (AdRSVeNOS) that carries cDNA for endothelial nitric oxide synthase (eNOS). Transfection of COS-1 cells with AdRSVeNOS increased nitric oxide synthase activity (measured as production of L-citrulline from L-arginine) that was calcium dependent and inhibited by N omega-nitro-L-arginine methyl ester. To investigate effects of overexpression of eNOS on vascular function, we incubated common carotid arteries from rabbits in organ culture with AdRSVeNOS or AdRSV beta gal encoding beta-galactosidase. Transgene expression and responses to vasoactive agents were examined 1 day after transduction. Histochemical staining of beta-galactosidase and immunohistochemistry for eNOS indicated transgene expression in endothelium and adventitial cells. After precontraction with phenylephrine, vessels treated with AdRSVeNOS demonstrated greater relaxation to acetylcholine than vessels treated with vehicle or AdRSV beta gal. Relaxation to calcium ionophore A-23187 was much greater in vessels treated with AdRSVeNOS than in vessels treated with vehicle or AdRSV beta gal. Augmented relaxation in response to A-23187 was also observed after denudation of endothelium in vessels treated with AdRSVeNOS and was inhibited by N omega-nitro-L-arginine. Thus vasorelaxation in response to stimuli that release nitric oxide is augmented after adenovirus-mediated overexpression of eNOS. Transgene expression in adventitial cells appears to be sufficient to alter vasomotor function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249499     DOI: 10.1152/ajpheart.1997.273.1.H265

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat.

Authors:  H C Champion; T J Bivalacqua; A L Hyman; L J Ignarro; W J Hellstrom; P J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Communication Is Key: Mechanisms of Intercellular Signaling in Vasodilation.

Authors:  Julie K Freed; David D Gutterman
Journal:  J Cardiovasc Pharmacol       Date:  2017-05       Impact factor: 3.105

3.  Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces the vasoconstrictive response.

Authors:  Y Maeda; U Ikeda; M Shimpo; S Ishibashi; T Takizawa; J Monahan; K Ozawa; K Shimada
Journal:  Exp Clin Cardiol       Date:  2001

Review 4.  Gene transfer for cerebrovascular disease.

Authors:  V G Khurana; Z S Katusic
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

5.  Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells.

Authors:  Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 6.  Gene therapy of hypertensive vascular injury.

Authors:  Y Chu; F M Faraci; D D Heistad
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

7.  Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice.

Authors:  Hunter C Champion; Trinity J Bivalacqua; Stanley S Greenberg; Thomas D Giles; Albert L Hyman; Philip J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

8.  Age-related neuronal vulnerability to brain ischemia: A potential target of gene therapy.

Authors:  H Ooboshi; S Ibayashi; H Yao; J Takada; D D Heistad; M Fujishima
Journal:  J Am Aging Assoc       Date:  2001-01

Review 9.  Gene therapy for cerebral vascular disease: update 2003.

Authors:  Kazunori Toyoda; Yi Chu; Donald D Heistad
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.

Authors:  Y Ohashi; S Kawashima; K i Hirata; T Yamashita; T Ishida; N Inoue; T Sakoda; H Kurihara; Y Yazaki; M Yokoyama
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.